These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 26845595)

  • 1. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
    Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
    Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.
    Sanchez-Pareja A; Clément S; Peyrou M; Spahr L; Negro F; Rubbia-Brandt L; Foti M
    World J Gastroenterol; 2016 Apr; 22(14):3735-45. PubMed ID: 27076758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?
    Craciun A; Lackner C; Cortez-Pinto H
    Curr Pharm Des; 2020; 26(10):1093-1109. PubMed ID: 31969088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
    Siddiqui MS; Charlton M
    Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis.
    Skladany L; Molcan P; Vnencakova J; Vrbova P; Kukla M; Laffers L; Koller T
    Can J Gastroenterol Hepatol; 2021; 2021():5576531. PubMed ID: 34095016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
    Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.
    Toshikuni N; Tsutsumi M; Arisawa T
    World J Gastroenterol; 2014 Jul; 20(26):8393-406. PubMed ID: 25024597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
    Tana C; Tana M; Rossi S; Silingardi M; Schiavone C
    J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
    Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
    Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.
    Raff EJ; Kakati D; Bloomer JR; Shoreibah M; Rasheed K; Singal AK
    J Clin Transl Hepatol; 2015 Mar; 3(1):9-16. PubMed ID: 26356325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.
    Tobari M; Hashimoto E; Taniai M; Ikarashi Y; Kodama K; Kogiso T; Tokushige K; Takayoshi N; Hashimoto N
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1404-1410. PubMed ID: 30590868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
    McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
    J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study.
    Shaheen AA; Kaplan GG; Sharkey KA; Lethebe BC; Swain MG
    Liver Int; 2021 Oct; 41(10):2308-2317. PubMed ID: 34037296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.